tbuckley/cabot-search huggingface dataset:
Prospective Trial Using Multimodal Measurable Residual Disease Negativity to Guide Discontinuation of Maintenance Therapy in Multiple Myeloma (MRD2STOP)
Authors: Ben A. Derman, Ajay Major, Sarah Major, Brittany D. Wolfe, Martha Gorski, Jennifer H. Cooperrider, Evangelia Andreatos, Ken Jiang, Karson Buckley, Amanda McIver, Andrew Stefka, Andrzej Jakubowiak
Journal: Blood (2022)
Development of Anti-CD3 Chimeric Antigen Receptor (CAR)-T Cells for Allogeneic Cell Therapy of Peripheral T-Cell Lymphoma (PTCL)
Authors: Hongliang Qian, Florence Pik Hoon Gay, Jane Wan Lu Pang, Yunqin Lee, Joshur Ang, Hwee Ching Tan, Erica SH Lek, Dario Campana, Ying Xim Tan
Journal: Blood (2022)
Impact of Dialysis Dependence on Survival for Multiple Myeloma Patients with Renal Impairment: A Multicenter Retrospective Study in China
Authors: Yuan Jian, Huixing Zhou, Weiwei Xie, Yuan Ren, Zhiyao Zhang, Guangzhong Yang, Chuanying Geng, Jing Jia, Wenming Chen, Jian Li, Wenrong Huang, Xinan Cen, Wen Gao
Journal: Blood (2022)
Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy
Authors: Xubin Li, Qing Deng, Jared Henderson, Grace Watson, Laurel Deaton, Taylor Cain, Luis Fayad, Swaminathan Padmanabhan Iyer, Fredrick B. Hagemeister, Loretta J. Nastoupil, Nathan H. Fowler, Jason Westin, Raphael Steiner, Ranjit Nair, Sairah Ahmed, Gheath Alatrash, Sattva S. Neelapu, Paolo Strati, Michael R Green
Journal: Blood (2022)
Pediatric Preclinical Testing Consortium Evaluation of the Anti-CD123 Antibody-Drug Conjugate, IMGN632, Against Patient-Derived Xenograft Models of Pediatric Acute Lymphoblastic Leukemia
Authors: Richard B Lock, Kathryn Evans, Joanna Randall, Stephen W Erickson, Eric J Earley, Steven Neuhauser, Tim Stearns, Vivek Philip, Beverly A Teicher, Krystal Watkins, Callum M Sloss, Patrick A Zweidler-McKay, Malcolm A Smith
Journal: Blood (2022)
Successful Restoration of Nivolumab Efficacy Post Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma
Authors: Khawlah Farhan, Abdulwahab Albabtain, Saud Alhayli, Walid Rasheed, Alfadel Alshaibani, Naeem A. Chaudhri, Ali Alahmari, Mahmoud Aljurf, Riad El Fakih
Journal: Blood (2022)
The Development of Allogeneic Tips-Derived TCR- CAR+ CD8αβ T Cells
Authors: Sjoukje J.C. van der Stegen, Roseanna M. Petrovic, Pieter L. Lindenbergh, Mame P. Diop, Vera Alexeeva, Hongyao Xie, Raedun Clarke, Bahram Valamehr, Isabelle Rivière, Michel Sadelain
Journal: Blood (2022)
Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer
Authors: Florian Moik, Simon Kraler, Fabrizio Montecucco, Luca Liberale, Stephan Nopp, Cornelia Englisch, Tetiana Lapikova-Bryhinska, Alexander Akhmedov, Arnold von Eckardstein, Florian A. Wenzl, Ingrid Pabinger, Thomas F. Lüscher, Cihan Ay
Journal: Blood (2022)
Efficacy and Safety Results from ASC4MORE, a Randomized Study of Asciminib (ASC) Add-on to Imatinib (IMA), Continued IMA, or Switch to Nilotinib (NIL) in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Not Achieving Deep Molecular Responses (DMRs) with ≥1 Year of IMA
Authors: Jorge E. Cortes, Timothy Hughes, Jan Geissler, Dong-Wook Kim, Elza Lomaia, Jiri Mayer, Anna G. Turkina, Sarah Hurwicz Kogut, Ana Paula Torres Cardoso, Monali Sura, Giuseppe Saglio
Journal: Blood (2022)
Function-Preserving Single Amino Acid Substitutions Shield Hematopoietic Stem and Progenitor Cells from CD117 Targeted Immunotherapy In Vivo
Authors: Romina Marone, Rosalba Lepore, Julia Rositzka, Viviane Dettmer-Monaco, Alessandro dell' Aglio, Giuseppina Capoferri, Julie Brault, Emiel Ten Buren, Thomas Burgold, Anna Camus, Christopher Divsalar, Laura Garcia Prat, Anna Haydn, Felix Hermann, Marcel Heugel, Andreja Knezevic, Frank Michael Lehmann, Valentin Do Sacramento, Alessandro Sinopoli, Lisa C Wellinger, Amélie Wiederkehr, Saniye Yumlu, Toni Cathomen, Thomas Winkler, Tatjana I Cornu, Stefanie Urlinger, Lukas T Jeker
Journal: Blood (2022)
Haemphagocytic Lymphohistiocytosis in an English Nationwide Cohort Confirms Increasing Incidence and Variation in Trigger Factors
Authors: Mark Bishton, Colin Crooks, Hanhua Liu, Lu Ban, Mary Bythell, Timothy Card, Peter Lanyon, Vasanta Nanduri, Judith Rankin, Peter Stilwell, Joe West
Journal: Blood (2022)
Age of Onset of Complications in Patients with Pyruvate Kinase Deficiency: Analysis from the Peak Registry
Authors: Andreas Glenthøj, Rachael F. Grace, Eduard J. van Beers, Joan-Lluis Vives Corrons, Bert Glader, Kevin H.M. Kuo, Carl Lander, Dagmar Pospíšilová, Hitoshi Kanno, Jean Williams, Yan Yan, Bryan McGee, Paola Bianchi
Journal: Blood (2022)
Base Editing of Hematopoietic Stem Cells Rescues T-Cell Development for CD3d Severe Combined Immunodeficiency
Authors: Grace McAuley, Gloria Yiu, Gregory A. Newby, Beatriz Campo Fernandez, Xiaomeng Wu, Patrick Chang, Kelcee Everette, Zulema Romero Garcia, David R. Liu, Gay M. Crooks, Donald B. Kohn
Journal: Blood (2022)
Patients with Deleterious Germline Variants in <i>STXBP2</i> Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel
Authors: Mark B. Leick, Seunghun Han, Kathleen M.E. Gallagher, Harrison Silva, Grace Martin, Sabrina Camp, Hoyin Chu, Riaz Gillani, Michael C. Kann, Bryan D. Choi, Rebecca Larson, Merle Phillips, Tamina Kienka, Stefanie R. Bailey, Charlotte Graham, Christopher R. Reilly, Max Jan, Elba Gonzalez, Nora K. Horick, Justin Budka, Simone Filosto, Rhine R. Shen, Eliezer Van Allen, Saud H AlDubayan, Marcela V. Maus
Journal: Blood (2022)
The Involvement of LAG3+ Plasma Cells in the Development of Multiple Myeloma
Authors: Natalia Kreiniz, Nasreen Eiza, Tamar Tadmor, Adi Sabag, Sarah Matarasso Greenfeld, Ilana Levy, Celia Surio, Ekaterina Votinov, Raeda Mubariki, Aaron Polliack, Elias Toubi, Zahava Vadasz
Journal: Blood (2022)
Oral Realgar-<i>Indigo Naturalis</i> Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16
Authors: Huaiyu Wang, Shu Chen, Xiaojuan Zhang, Xinhua Lu, Sha Gong, David Wald, Haitao Zhang, Jing Li
Journal: Blood (2022)
Immune Escape after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
Authors: Sanam Shahid, Nicholas Ceglia, Jean-Benoit Le Luduec, Andrew McPherson, Barbara Spitzer, Viktoria Bojilova, M. Kazim Panjwani, Mikhail Roshal, Sohrab Shah, Omar Abdel-Wahab, Benjamin Greenbaum, Katharine C. Hsu
Journal: Blood (2022)
Chromatin Architecture Protein CTCF Plays a Role in Determining 5-Azacytidine Response of Leukemic Cells By Potentially Regulating Hoxb Genes
Authors: Aparna Gopal, Derek Tam, Ryan J. Stubbins, Kieran O'Neill, Marion Shadbolt, Deborah Deng, Rena Buckstein, Aly Karsan
Journal: Blood (2022)
Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia
Authors: Georgia Koutsoumpli, Dyantha I. van der Lee, Nina C. Groenland, M. Willy Honders, Rob C.M. de Jong, Renate S. Hagedoorn, Hendrik Veelken, Peter A. van Veelen, Dominik Lock, Mirjam H.M. Heemskerk, J.H.Frederik Falkenburg, Ian Johnston, Marieke Griffioen
Journal: Blood (2022)
Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy
Authors: Samer Al Hadidi, Aniko Szabo, Jean Esselmann, Lindsay Hammons, Munawwar Hussain, Yetunde Ogunsesan, Nishanth Thalambedu, Fatima Khan, Jaskirat Sethi, Abhishek Janardan, Sabarinath Radhakrishnan, Sharmilan Thanendrarajan, Carolina Schinke, Binod Dhakal, Siegfried Janz, Saurabh Chhabra, Anita D'Souza, Maurizio Zangari, Frits van Rhee, Meera Mohan
Journal: Blood (2022)
MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials &amp; Implications for Clinical Trial Design
Authors: Mark Roschewski, David M. Kurtz, Jason Westin, Ryan C. Lynch, Charles Macaulay, Christian Kuffer, Gregory J. Hogan, Sandra Close, Jacob J. Chabon, Davide Rossi, Maximilian Diehn, Ash A. Alizadeh, Andre Schultz
Journal: Blood (2022)
Pathogenic Germline Variants in a Prospective Multi-Center Cohort of Patients with Multiple Myeloma
Authors: Julia E. Wiedmeier, Michael A. Golafshar, Katie L. Kunze, Edward D. Esplin, Robert L. Nussbaum, A. Keith Stewart, Jewel Samadder, P. Leif Bergsagel, Rafael Fonseca
Journal: Blood (2022)
In Vivo PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Autologous and Allogeneic Chimeric Antigen Receptor T-Cell Immunotherapy
Authors: Won Lee, Destanie Rose, Mingshan Cheng, Heather Gustafson, Rebecca A Gardner, James G Keck, Jiwon Yang
Journal: Blood (2022)
Immune Reconstitution Following Infusion of Autologous Blinatumomab Expanded T-Cells (BET) in CD20+ Indolent Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Receiving Front-Line Treatment with Fludarabine-Cyclophosphamide-Rituximab or Bendamustine-Rituximab
Authors: Giuseppe Gritti, Federico Lussana, Silvia Ferrari, Anna Maria Barbui, Francesco Landi, Giulia Quaresmini, Gianmaria Borleri, Muriel Paganessi, Chiara Pavoni, Elisa Gotti, Chiara Capelli, Josee Golay, Martino Introna, Alessandro Rambaldi
Journal: Blood (2022)
Human Models of <i>NUP98</i>-Rearranged Leukemia Reveal Fusion-Specific Molecular Mechanisms
Authors: Masayuki Umeda, Nicole L. Michmerhuizen, Ryan Hiltenbrand, Juan M. Barajas, Bright Arthur, Sherif Abdelhamed, Jing Ma, Tamara Westover, Jonathan Miller, Charles G. Mullighan, Jeffery M. Klco
Journal: Blood (2022)
Safety and Efficacy of CD19 CAR-T Cells for Refractory Systemic Sclerosis: A Phase I Clinical Trial
Authors: Jingjing Feng, Yongxian Hu, Mingming Zhang, Heng Cao, Yini Ke, Huijun Xu, Jiazhen Cui, Yanlei Zhang, Alex Hongsheng Chang, Jin Lin, Guoqing Wei, He Huang
Journal: Blood (2022)
Global Health Status Inadequately Captures Longitudinal Changes in Quality of Life in Patients Receiving Carfilzomib for Multiple Myeloma: Electronic Patient-Reported Outcomes (ePROs) from a Prospective Observational Study
Authors: Ajay Major, Nicole Prabhu, Claire Cunningham, Jennifer H. Cooperrider, Hannah Johnston, Evangelia Andreatos, Martha Gorski, Sarah Major, Brittany D. Wolfe, Eric Kruse, Ben A. Derman, Roberto M. Lang, Andrzej Jakubowiak, Jeanne DeCara
Journal: Blood (2022)
Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)
Authors: Zhijian Xiao, Chunkang Chang, Qiubai Li, Xiaojing Yan, Tiejun Qin, Hongyan Tong, Yu Zhang, Min Dai, Yanjie He, Jianyu Weng, Jian Li, Sujun Gao, Rong Fu, Xudong Wei, Aili He, Jinhai Ren, Tong Wu, Xin Du, Yanni Zhang, Ke Xu, Zhengyi Wang, Michelle Yang, Andrew Zhu
Journal: Blood (2022)
Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Is an Independent Prognostic Factor for Multiple Myeloma and Could Complement Prognosis Value of Minimal Residual Disease
Authors: Sunil Lakhwani, Laura Rosinol Dachs, Noemi Puig, Miguel Angel Pico Picos, Laura Medina-González, Joaquín Martínez-López, Bruno Paiva, Albert Oriol, Rafael Rios, María Jesús Blanchard, Isidro Jarque, Joan Bargay, Jose Maria Moraleda, Estrella Carrillo-Cruz, Anna Sureda, Isabel Krsnik, Esther González Garcia, Luis Felipe Casado Montero, Josep M Marti, Cristina Encinas, Felipe De Arriba, Luis Palomera, Antonia Sampol, Yolanda Gonzalez-Montes, Cristina Motllo, Javier De La Cruz, Rafael Alonso Fernández, María-Victoria Mateos, Joan Bladé Creixenti, Juan-José Lahuerta, Jesús San-Miguel, Miguel-Teodoro Hernández
Journal: Blood (2022)
Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy
Authors: Gloria Iacoboni, Josu Iraola-Truchuelo, Alberto Mussetti, Paula Fernández-Caldas, Víctor Navarro Garcés, ANA Africa Martin Lopez, Javier Delgado, Ariadna Pérez Martínez, Manuel Guerreiro, Ana Carolina Carolina Caballero Gonzalez, Nuria Martínez-Cibrián, Hugo Daniel Luzardo Henriquez, Jose M. Sanchez, Juan-Manuel Sancho, Pere Barba, Mi Kwon, Lucía López Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Alejandro Martín García-Sancho, Mariana Bastos-Oreiro, Pau Abrisqueta
Journal: Blood (2022)
In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating mRNA
Authors: Laura Breda, Tyler E Papp, Michael Triebwasser, Amir Yadegari, Megan T Fedorky, Naoto Tanaka, Houping Ni, Drew Weissman, Stefano Rivella, Hamideh Parhiz
Journal: Blood (2022)
Differences in Single Cells between BCMA-Targeting CAR T-Cell Therapy Responders and Non-Responders Reveals Initial Resistance and Acquired Resistance Are Driven By Different Factors
Authors: Mehmet K. Samur, Nathan Martin, Ethan Thompson, Mariateresa Fulciniti, Anil Aktas-Samur, Shari Kaiser, Nikhil C Munshi
Journal: Blood (2022)
Adjuvant Systemic Therapy in High Risk Solitary Bone Plasmacytoma: Results of the UK Randomised Phase III IDRIS Study (CR UK/14/032)
Authors: Kushani Ediriwickrema, Neil K Rabin, Shirley D'Sa, Graham Jackson, Peter Hoskin, Eve Gallop-Evans, Patricia Diez, Catherine Parbutt, Andre Lopes, Sevasti Galani, Laura Clifton-Hadley, Darren Edwards, Husne Timur Tezver, Ruth M. de Tute, Andrew Bates, Roger G Owen
Journal: Blood (2022)
Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with <i>FLT3</i>-Internal Tandem Duplication: Results from the Quantum-First Trial
Authors: Richard F. Schlenk, Pau Montesinos, Antonio Romero-Aguilar, Radovan Vrhovac, Elżbieta Patkowska, Hee-Je Kim, Pavel Zak, Po-Nan Wang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Aziz Benzohra, Arnaud Lesegretain, Jorge E. Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Alexander E. Perl, Mark J. Levis, Harry P. Erba
Journal: Blood (2022)
Single-Cell RNA Sequencing of Rare Circulating Tumor Cells in Precursor Myeloma Patients Reveals Molecular Underpinnings of Tumor Cell Circulation
Authors: Elizabeth D. Lightbody, Danielle T. Firer, Romanos Sklavenitis-Pistofidis, Junko Tsuji, Michael P. Agius, Ankit K. Dutta, Ting Wu, Hadley Barr, Mahshid Rahmat, Yoshinobu Konishi, Michelle P. Aranha, Michael Vinyard, Jean-Baptiste Alberge, Nang Kham Su, Cody J. Boehner, Laura Hevenor, Habib El-Khoury, Katherine Towle, Christian J. Cea-Curry, Erica Horowitz, Jacqueline Perry, Anna Cowan, Anna V. Justis, Daniel Auclair, Catherine R. Marinac, Gad Getz, Irene Ghobrial
Journal: Blood (2022)
Safety and Efficacy of CD22 and CD19 Chimeric Antigen Receptor T Cell Treatment Bridging to Autologous Stem Cell Transplantation As Consolidation Therapy for B-Cell Acute Lymphoblastic Leukemia
Authors: Yan Qiu, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Li-Qing Kang, Ai-Ning Sun, De-Pei Wu, Lei Yu, Shengli Xue
Journal: Blood (2022)
Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in &amp;lt;3 Days Using the High-Performance Platform
Authors: Hui Liu, Ting Wang, Yazi Yang, Ru Feng, Jiangtao Li, Chunli Zhang, Jiefei Bai, Yanping Ding, Guanghua Liu, Fei Wu, Xinan Lu, Jian Li, Ting He
Journal: Blood (2022)
Voxelotor Treatment Leads to Improved Viability of Sickle Erythrocytes and Altered Neutrophil Phenotype
Authors: Kadère Konté, Aafke E. Gaartman, Boukje M. Beuger, Martijn Veldthuis, Rob van Zwieten, Robin Van Bruggen, Bart J. Biemond, Erfan Nur
Journal: Blood (2022)
<i>End-of-Life Care in Hospitalized Patients with Hematologic Malignancies: A Retrospective Unicentric Study</i>
Authors: Alberto Lázaro García, Marta González Rodríguez, Edwin Uriel Suárez Merchán, Gonzalo Castellanos Arias, Alicia de las Heras Moreno, María Pilar Llamas Sillero, Eduardo García Romo, Antonio Noguera Tejedor, Laura Solán Blanco, Antonio Herrero, Juan Manuel Alonso Dominguez
Journal: Blood (2022)
A Quantitative Systems Pharmacology Modeling Framework for Evaluation of Cytokine Release Mediated By Intravenous Odronextamab Monotherapy in Patients with B-Cell Non-Hodgkin Lymphoma
Authors: Masood Khaksar Toroghi, Min Zhu, Jurriaan Brouwer-Visser, Srikanth R. Ambati, Hesham Mohamed, Aafia Chaudhry, John D. Davis, A. Thomas DiCioccio
Journal: Blood (2022)
Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient
Authors: Ahmed Aribi, Lihua E Budde, Joseph C. Alvarnas, Eileen P. Smith, Amandeep Salhotra, Monzr M. Al Malki, Wen Yi-Ping, John Zaia, Guido Marcucci, Jana Dickter, Stephen J Forman
Journal: Blood (2022)
IFN-γ Primed Wharton's Jelly Mesenchymal Stromal Cells Inhibit T Cell Proliferation By Synergistic IDO and Mitochondrial Transfer Mechanisms
Authors: Cecile Pochon, Romain Perouf, Allan Bertrand, Anne-Béatrice Notarantonio, Naceur Charif, Marcelo De Carvalho Bittencourt, Guillemette Fouquet, Ghislaine Cauchois, Charlotte Voisin, Danièle Bensoussan, Patrick Emond, Hervé Sartelet, David Moulin, Natalia de Isla, Maud d'Aveni, Marie Thérèse Rubio
Journal: Blood (2022)
Bortezomib Maintenance Appears Feasible, Safe and Effective in Newly Diagnosed Multiple Myeloma in a Resource Limited Setting - a Retrospective Analysis from South India
Authors: Rashmi Suresh Yawalkar, Mobin Paul, Reshmy G S, Mrudula E.V., Rema Ganapathy, Manoj Unni, Chitresh Yadav, Shreya Gopal Agrawal, Sandeep abhijit Pattanik, Gohul Gopi Jalajakumari,, Aswathy Ashok Beenakumary, Anjaly s Nair, Ullas Mony, Neeraj Sidharthan
Journal: Blood (2022)
Discordance between Patient Goals and Treatment in Older AML Patients
Authors: Sara Marie Tinsley-Vance, Cecile A. Lengacher, Andrew Kuykendall, Daniel Lastorino, Amaya Oyola, Onyee Chan, Eric Padron, Areej El-Jawahri, David A. Sallman, Kendra Sweet, Jeffrey E. Lancet, Rami S. Komrokji
Journal: Blood (2022)
An Ongoing Pilot Study of Targeted Radioimmunotherapy (131-I Apamistamab) Conditioning Prior to CD19-Targeted CAR T-Cell Therapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Authors: Mark B. Geyer, Briana Cadzin, Kinga Hosszu, Brigitte Senechal, Jennifer A. Spross, Alexis Mark, Avinash Desai, Elizabeth R. Cathcart, M. Lia Palomba, Neeta Pandit-Taskar
Journal: Blood (2022)
Early and Deep Molecular Responses Achieved with Frontline Asciminib in Chronic Phase CML - Interim Results from ALLG CML13 Ascend-CML
Authors: David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes S.M. Yong, Jake Shortt, Kate Burbury, Nicholas Viiala, Ilona Cunningham, David M. Ross, Rosemary Harrup, Matthew Wright, Cecily Forsyth, Alwyn Bernard D'Souza, Robin J Filshie, Peter J. Browett, Steven W Lane, Carolyn Grove, Andrew Grigg, Timothy Hughes
Journal: Blood (2022)
Patients with B Cell Malignancy That Lacked Immune Response to Sars-Covid-2 Vaccination Mount Antibody Response Following Actual Sars-Covid-2 Infection: Potential to Improve Vaccination Strategy
Authors: Hamza Hassan, June Corrigan, Nathanael R Fillmore, Jennifer La, Nhan V Do, Mary Brophy, Nikhil C Munshi
Journal: Blood (2022)
Genomic Landscape of IgM MGUS and Asymptomatic Waldenström Macroglobulinemia Patients
Authors: Tina Bagratuni, Foteini Aktypi, Nefeli Mavrianou-Koutsoukou, Dimitrios Patseas, Christine Ivy Liacos, Stamatia Skourti, Alexandra Papadimou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis
Journal: Blood (2022)
Comprehensive Genomic Landscape and Clonal Architecture in Pediatric Patients with Monosomy 7
Authors: Tamara Westover, Sherif Abdelhamed, Emily Xiong, Michael P Walsh, Jing Ma, Jasmine C. Wong, Astrid Behnert, Mignon L. Loh, Kevin M. Shannon, Jeffery M. Klco
Journal: Blood (2022)
Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma
Authors: Christian Straka, Kerstin Schaefer-Eckart, Bernd Hertenstein, Florian Bassermann, Hans Salwender, Christian Langer, Jan Krönke, Miriam Kull, Georgia Schilling, Aneta Schieferdecker, Monika Engelhardt, Stefan Knop, Julia Reusch, Wolf Roesler, Bernd Metzner, Holger Hebart, Albrecht Reichle, Matthias Grube, Norbert Frickhofen, Christian Gerecke, Stephan Fuhrmann, Wolfram Jung, Martin Gramatzki, Thomas Decker, Tobias Dechow, Jochen Greiner, Tim H. Brümmendorf, Juliana Ababei, Ivana von Metzler, Ralph Naumann, Elisabeth Fritz, Marcus Hentrich, Peter Bojko, Thomas Kubin, Christian Schmidt, Martin Kaufmann, Burkhard Schmidt, Axel Hinke, Hermann Einsele
Journal: Blood (2022)
Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China
Authors: Zhe Zhuang, Ying Tian, Hong Yu, Lei Shi, Wei-wei Tian, Qinhua Liu, Dongmei Zou, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Wanling Sun, Liangming Ma, Li Bao, Rong Fu, Yin Wu, Chen Wenming, Junling Zhuang
Journal: Blood (2022)
The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes
Authors: Derya Koyun, Guldane Cengiz, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topçuoğlu, Muhit Özcan, Onder Arslan, Taner Demirer, Osman İlhan, Gunhan Gurman, Meral Beksac, Meltem Kurt Yuksel
Journal: Blood (2022)
Novel Tissue-Specific Targeted Radiation Delivery Reduces GI Injury and T Cell Trafficking Attenuating Allogeneic Immune Attack to Reduce GvHD in a Murine BMT Model
Authors: Srideshikan Sargur Madabushi, Hemendra Ghimire, Ji Eun Lim, Paresh Vishwasrao, Amr M H Abdelhamid, Guy Storme, Cynthia Aristei, Loredana Ruggeri, Dörthe Schaue, Monzr M. Al Malki, Amandeep Salhotra, Antonio Pierini, Susanta Hui
Journal: Blood (2022)
Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study
Authors: Cyrille Hulin, Aurore Perrot, Margaret Macro, Anne Vekhoff, Xavier Leleu, Lionel Karlin, Salomon Manier, Laure Vincent, Abderrazak El Yamani, Wajed Abarah, Régis Kaphan, Charles Zarnitsky, Daniel Re, Laure Christophe, Olivier Fitoussi, Nathalie Texier, Raphael Germain, Marion Willaime, Olivier Decaux
Journal: Blood (2022)
Characteristics and Prognostic Effects of DNMT3A Co-Mutations
Authors: Alireza Torabi, Todd A. Alonzo, Megan Othus, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Jerald P. Radich, Frederick R. Appelbaum, Kristin O'Dwyer, Harry P. Erba, Martin S. Tallman, Mark R. Litzow, Ehab L. Atallah, Selina M. Luger, Anders E. Kolb, Omar Abdel-Wahab, Derek Stirewalt, Ross L. Levine, Elisabeth Paietta, Soheil Meshinchi
Journal: Blood (2022)
A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)
Authors: Xudong Zhang, Wenhua Wang, Shanshan Ma, Mengke Fan, Linan Zhu, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Mingzhi Zhang
Journal: Blood (2022)
Clonal Hematopoiesis: Exploiting Molecular Landscape of Multiple Myeloma Patients for Choosing the Most Appropriate Therapeutic Strategy
Authors: Elisa Gelli, Antonella Laudisi, Claudia Martinuzzi, Debora Soncini, Pamela Becherini, Fabio Guolo, Concetta Conticello, Daniele Derudas, Francesco Di Raimondo, Antonia Cagnetta, Domenico Coviello, Roberto Massimo Lemoli, Michele Cea
Journal: Blood (2022)
Light Chain(AL) Cardiac Amyloidosis: A Real World Data on Therapy and Outcomes
Authors: Sandeep Abhijit Pattnaik, Hisham Ahamed, Chitresh Yadav, Manoj Unni, Varsha K Rajeev, Vasundhara Raina, Nikhil Krishna Haridas, Rema Ganapathy, Mobin Paul, Ullas Mony, Neeraj Sidharthan, Damodhar Reddy Gouni, Rashmi Suresh Yawalkar, Shreya Gopal Agrawal, Gohul Gopi Jalajakumari
Journal: Blood (2022)